Therna Biosciences Appoints Biotech Veteran Devyn Smith, Ph.D., to Board of Directors and Expands Strategic and Scientific Advisory Leadership
Appointments expand leadership across AI, RNA biology, and delivery innovation with additions of Ron Philip, Brian Hie, Ph.D., Bo Wang, Ph.D., and Hamideh Parhiz, Pharm.D., Ph.D.
Therna Biosciences Appoints Biotech Veteran Devyn Smith, Ph.D., to Board of Directors and Expands Strategic and Scientific Advisory Leadership
Therna Biosciences Launches with Proprietary Generative AI Models for Designing Programmable RNA Medicines
Therna Biosciences today announced its launch with a vision to transform the development of RNA medicines through a biology-guided, AI-powered platform. By decoding the language of RNA, Therna is pioneering programmable RNA therapeutics engineered for enhanced translation, durability, immune evasion, and precise tissue targeting – unlocking new levels of safety, efficacy, and therapeutic potential…